RSS

ProBioGen

ProBioGen (service and technology provider for complex therapeutic glycoproteins) and Pionyr Immunotherapeutics have initiated a second immune-oncology contract development and manufacturing project. more

News

German service and technology provider, ProBioGen, and immune-oncology company, Surface Oncology, have signed a second antibody development project for the development and manufacture of another antibody for potential use in clinical trials. more

News

Another global pharmaceutical company has licensed ProBioGen’s GlymaxX ADCC-enhancement technology. The license covers the modification of the pharmaceutical company's antibody production platform for the generation of antibodies with enhanced... more

Technology